Multiparametric magnetic resonance imaging (mpMRI) is an integral component of prostate cancer diagnostics. According to the S3 guidelines on prostate cancer, mpMRI should be used for the primary diagnostics of prostate cancer as well as in active surveillance (AS). Basically, mpMRI consists of high-resolution T2-weighted (T2w) sequences, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) sequences, which in turn are the basis for structured reporting according to the prostate imaging reporting and data system (PI-RADS) classification.
Keyphrases
- prostate cancer
- diffusion weighted imaging
- contrast enhanced
- magnetic resonance imaging
- high resolution
- radical prostatectomy
- diffusion weighted
- magnetic resonance
- computed tomography
- adverse drug
- deep learning
- machine learning
- mass spectrometry
- clinical practice
- emergency department
- big data
- network analysis
- fluorescence imaging